Development of a unique rapid test to detect antibodies directed against an extended RBD of SARS-CoV-2 spike protein

Researchers at University of Applied Sciences and Arts Northwestern Switzerland FHNW worked to develop a rapid test that measures patient immune protection from SARS-CoV-2, resulting from prior infection or vaccination. Their work utilized INFORS HT's Techfors-S pilot bioreactor.